Abstract
INTRODUCTION
Transposition of the great arteries (TGA) represents a complex congenital cyanotic cardiac malformation, often leading to death within the first year of life if left untreated. The first surgical treatments of TGA were the atrial switch operations, performed by Senning and Mustard for the first time in 1958 and 1964, respectively [1, 2] . In 1975, however, the arterial switch operation (ASO) was introduced, which fully restored the correct anatomical structure of the heart and, over time, became the primary method of choice for the surgical correction of TGA [3] .
Previous studies regarding late results after ASO, Mustard and Senning included follow-up periods extending to a maximum of 30 years, yet remain limited to single centres or small follow-up coverage [4] [5] [6] [7] [8] . In this study, we report the survival of TGA patients up to 43 years after the procedure.
METHODS
We received permission to perform this study from the Finnish Ministry of Social Affairs and Health. All research received approval from the Ethical Committee of Helsinki University Central Hospital.
Patients and data collection
We used the custom-built ProCardio version 8 database, which included the Research Registry of Paediatric Cardiac Surgery (Melba Group, Helsinki, Finland) running on Filemaker Pro version 12 (Filemaker Inc., Santa Clara, CA, USA) and occasionally paper archives to obtain patient and surgical data. The database and data gathering have been described previously in detail [9] . This study included all TGA patients undergoing a Senning, a Mustard or an ASO procedure from 1968 to 2009 in Finland. We excluded TGA patients with double-outlet right or left ventricle and congenitally corrected TGAs.
The follow-up period ended on 24 October 2012. We included only those patients under 18 years of age at the time of their first operation. Patients were divided into 3 groups according to their surgical procedure (Mustard, Senning or ASO) . Complex TGA included all patients with an accompanying ventricular septal defect, coarctation of the aorta, coronary malformation or pulmonary valve stenosis.
Mortality and survival
All patient deaths within 30 days postoperatively were defined as early operative mortalities. Long-term follow-up started immediately after the patient's Mustard, Senning or ASO procedure and ended at the patient's death or 24 October 2012.
Causes of death
Patient deaths were first categorized based on congenital heart defect (CHD)-related and non-CHD-related causes of deaths. CHD-related deaths were classified as diseases falling within the Q20-Q28 range of the International Classification of Diseases (ICD-10) diagnostic system (or 745-747 in ICD-9 for older cases).
All CHD-related deaths were further categorized as heart failure, sudden, perioperative and cardiovascular deaths according to a classification system described previously [10] . Sudden deaths included all non-witnessed deaths during sleep and cardiovascular-related deaths occurring within 1 h of onset (or a significant worsening) of symptoms. Perioperative deaths included all early operative deaths (within 30 days) that occurred after the patients' subsequent operations. The remaining causes of death not covered by the other categories of death were classified as cardiovascular.
Statistical analyses
We used IBM SPSS Statistics version 22.0 (IBM Corp., Released 2013, IBM SPSS Statistics for Mac, Version 22.0. Armonk, NY, USA) and R program with epi and splines packages (R Development Core Team, Vienna, Austria) for all statistical analyses. For normally distributed variables, we performed 2-group comparisons using the Student's t-test and used the one-way analysis of variance relying on the Dunnett's post hoc test for multiple group comparisons. For non-normally distributed variables, we performed 2-group comparisons using the Mann-Whitney test and multiple group comparisons using the Kruskal-Wallis test. Cox regression was used to obtain hazard ratios (HRs) for test variables, late survival and reoperation-free survival. We also utilized the Fine-Gray subdistribution hazard model to analyse reoperation-free survival. The method is suitable for predicting prognosis or estimating incidence in the presence of competing risks, death and reoperation in this case. We analysed hazard rates for different causes of death without competing risks using a Poisson regression model with a Lexis-type data structure with 3 time scales: age, calendar year and time since the operation. The model shows estimates of hazard function based on Poisson regression with natural cubic splines. To estimate the hazard rate curves, splines were used to produce smoothed curves with a 95% interval.
RESULTS

Patients
In total, 547 paediatric patients were treated for TGA between 1961 and 2009 in Finland. Among these, 470 patients (86%) underwent a Mustard, a Senning or an ASO procedure for their defect and were thus included in our study. The remaining 77 patients underwent either a Rastelli, systemic-to-pulmonary shunt, ASD creation or other palliative procedures and were thus excluded from the study. The first of the study patients underwent TGA surgery in 1968. Complete follow-up data were available for 463 (99%) patients, and 7 patients were excluded due to insufficient follow-up data. The Mustard procedure was performed on 81 patients (17%), Senning on 130 (28%) and ASO on 252 (54%) ( Table 1 ). Since 1990, nearly all patients were treated using the ASO procedure. The number of ASO procedures steadily increased since the 1970s (Fig. 1A) .
Early (<30 days postoperative) and late surgical results Table 2 ), with 10-year survival rates of 98% (95% CI 96-100%), 82% (95% CI 73-91%) and 91% (95% CI 86-96%); and 20-year survival rates of 97% (95% CI 95-100%), 78% (95% CI 68-87%) and 84% (95% CI 77-90%) excluding early mortality, respectively. When including early mortality, however, the difference in survival between Senningand ASO-operated patients diminished but remained for Mustardoperated patients (Table 2) . Also, in a multivariate Cox regression model including operative age, operative era, prior operations, defect complexity and procedure type, the statistically significant effect of ASO on late survival was cancelled (Table 2) .
Patients with simple TGA who underwent the Senning procedure had a 30-year survival of 85% (95% CI 77-92%) vs 54% (95% CI 37-71%) for those with complex TGA (HR 3.3, 95% CI 1.6-6.7, P = 0.001; Fig. 3 ). Similarly, patients with simple TGA who underwent the ASO procedure had a 20-year survival of 92% (95% CI 87-96%) vs 77% (95% CI 68-86%) for those with complex TGA (HR 3.0, 95% CI 1.5-6.0, P = 0.002; Fig. 3 ). Univariate analyses revealed that complex disease increased the risk of death in Senning-and ASO-operated patients but not Mustard-operated patients (Table 2 ). This difference was reduced when excluding early mortality from the analysis ( Table 2 ). In a multivariate Cox regression model, complex TGA remained a significant risk for death (HR 2.4, 95% CI 1.5-3.6, P < 0.0001). Removing early deaths did not affect these results.
Reinterventions
Patients with simple TGA who underwent the Senning procedure had a 30-year reoperation-free survival of 84% (95% CI 73-91%) vs 65% (95% CI 49-80%) for those with complex TGA (HR 2.3, 95% CI 1.1-4.9, P = 0.032; Fig. 3 , Table 2 ), including early mortality. For patients who underwent the ASO, a simple defect resulted in a 15-year reoperation-free survival of 85% (95% CI 78-92%) vs 71% (95% CI 60-82%) for those with complex disease (HR 2.2, 95% CI 1.2-4.0, P = 0.009; Fig. 3 , Table 2 ), including early mortality. In a univariate competing risk analysis, patients who underwent the Senning and Mustard procedures had a significantly lower risk for reoperation than patients who underwent the ASO both including and excluding early 30-day mortality, whereas Cox regression revealed no such differences (Table 2 ). In a multivariate competing risk model, this significance was reduced ( Table 2) . Complex TGA was a risk factor for reoperation in none of the procedure groups in the competing risk analyses, both including and excluding early mortality (Table 2) . However, in a univariate Cox regression model, ASO-operated patients with complex TGA had a significant risk for reoperation compared with patients with simple TGA (Table 2 ). This was also the case for Senning-operated patients with complex TGA, both including and excluding early mortality (Table 2 ). In a multivariate Cox The multivariate model included prior operations, era of operation, operative age and defect complexity. TGA: transposition of the great arteries; ASO: arterial switch operation; HR: hazard ratio; CI: confidence interval.
regression model, but not competing risk analysis, complex TGA increased the risk of reoperations when including early mortality for all patients (HR 1.8, 95% CI 1.2-2.7, P = 0.004). Pulmonary artery stenosis represented the most common type of reintervention after ASO, while pacemaker implantation followed the Senning and Mustard procedures. All reoperations are presented in Supplementary Material, Table S1 .
Risk factors for death
In a multivariate Cox regression model including early mortality, complex TGA (HR 2.4, 95% CI 1.5-3.6, P < 0.0001), earlier era of operation (HR 2.9 <2000s vs 2000s, 95% CI 1.1-7.7, P = 0.03) and prior operations (HR 1.9, 95% CI 1.0-3.3, P = 0.03) were identified as significant risk factors for death. When excluding early mortality, complex TGA (HR 2.1, 95% CI 1.2-3.9, P = 0.008) and the Senning (HR 6.4, 95% CI 1.1-38.2, P = 0.04), but not the Mustard operation, increased the risk of death, whereas era of operation and prior operations lost their significance as predictors.
Causes of death
Fatal heart failure represented the most common cardiac-related cause of death among patients in the Mustard procedure group, sudden death was most common among patients in the Senning group and cardiovascular-related causes most common among ASO patients (Fig. 4, Table 3 ). The hazard rate for fatal heart failure showed a bimodal distribution among Mustard and Senning patients ( Fig. 4A and B) . No sudden deaths or fatal heart failures occurred among patients who underwent the ASO procedure (v 2 = 12.94, degree of freedom 2, and P = 0.002 for the log-rank test; Table 3 , Fig. 4C ). Only 5 patients undergoing ASO died late postoperatively, 2 from cardiovascular-related reasons (Fig. 4C, Table 3 ), 2 from perioperative deaths after subsequent reinterventions and 1 from reasons not related to the cardiac defect.
DISCUSSION
The comprehensive nationwide registry in Finland allowed us a unique opportunity to perform a population-based study of these patients, which included a lengthy follow-up period and excellent patient coverage.
Early and late mortality
Historically, the advent of ASO was shadowed by a relatively high incidence of operative mortality. We now see that late results up to 30 years postoperatively are superior to those for patients undergoing the Senning and Mustard procedures. Nevertheless, perioperative deaths after ASO were higher than after the Mustard or Senning procedures, primarily due to the early onset of coronary artery-related complications [11] [12] [13] [14] . The survival rate of patients after the ASO procedure, however, plateaus at 86% after 10 years, whereas survival among Senning and Mustard patients continues to decrease, mostly due to the late manifestation of arrhythmias and heart failure. Furthermore, excluding early mortality brings the survival rate of ASO-treated patients close to that of the general population (99%).
In general, postoperative results for cardiac defects improved in recent eras [9, 15] . Additionally, the results after the ASO procedure improved significantly in 2000-2009 primarily due to a decrease in early adverse postoperative coronary events. Other studies previously reported improved results after the ASO procedure, largely attributed to advances in techniques used to translocate the coronary arteries [8, [16] [17] [18] [19] [20] . The learning curve for adopting the ASO in our material was steep, accompanied by the continuous introduction of new techniques to improve coronary circulation and to prevent right ventricular outflow tract obstruction, such as the trapdoor incision, right coronary artery implantation above the aortic suture line and the LeCompte manoeuvre, together with the Pantaloon pericardial patch in the reconstruction of the neopulmonary root [8, [16] [17] [18] [19] [20] .
Modes of death
Manipulation of the right atrium during the Senning and Mustard procedures may cause damage to the sinus node or atrial conducting tissue, which manifests as atrial bradyarrhythmias or tachyarrhythmias [21, 22] . Sudden death is recognized as one of the major challenges after the Senning and Mustard procedures and was also confirmed by this study. Convincing prognostic factors remain unidentified; thus far, only mild electrocardiographic findings and symptoms of heart failure have been suggested [23, 24] . The atrium-sparing technique in the ASO procedure, however, was previously found to minimize the risk of sudden death [4, 7, 25, 26] . Our study confirms this, with no such cases during a 30-year follow-up among our patients.
Manipulation and transfer of the coronary outflow tracts to the root of the neoaorta during the ASO procedure predisposes the coronary circulation to stenosis [27] . Only 2 of our ASO patients died due to late coronary events. In Finland, however, coronary angiographies are not routinely performed on asymptomatic patients, leaving the actual incidence of coronary lesions unknown. Patients, however, undergo stress testing during adolescence and those with signs of ischaemia are scheduled for coronary angiography. Some previous studies used routine coronary angiographies to show that asymptomatic coronary lesions occur frequently following ASO and suggest the routine monitoring of these patients [12, 13] .
The Mustard and Senning procedures maintain the right ventricle as the systemic ventricle. This factor combined with tricuspid regurgitation and chronic arrhythmias may lead to heart failure. The ASO procedure, however, restored the normal anatomy of the heart and offered a more favourable physiological outcome. Nevertheless, this requires a left ventricle capable of coping with the high systemic blood pressure. Performing the procedure quite Total (%) 20 (28) 25 (20) 5 (4) 50 (12) early after birth solved this issue, and, accordingly, in our sample, we observed no late deaths due to heart failure after ASO.
Pulmonary artery stenosis stands as the most common reason for reintervention after ASO, warranting late pulmonary reconstruction [4] . This was also the case in our study, with the vast majority of obstructions located in the main pulmonary artery and some in the branching vessels. However, later incorporation of the LeCompte manoeuvre and the pericardial Pantaloon patch to ASO during the late 1990s significantly reduced the incidence of subsequent pulmonary stenosis, which was also reported in previous studies [28] . Pacemaker implantation was the most common reason for reintervention after the Senning and Mustard procedures. Six patients from each of the Mustard and Senning groups underwent reintervention due to tricuspid valve insufficiency. The competing risk analysis revealed that Senning and Mustard-operated patients had higher reoperation-free survival than ASO-operated patients, which suggests a trade-off between improved survival but higher need for reoperation with the ASO. The difference in the results between the competing risk analysis and the traditional Cox regression analysis is most likely explained by the higher incidence of death in the Senning and Mustard groups, which causes the Cox regression model to overestimate the incidence of the primary outcome (reoperation) in these groups. However, the aforementioned new techniques in the ASO procedure may change this outcome in the future.
Limitations
Since 1990, our hospital has almost exclusively relied on ASO for the correction of TGA. Coincidentally, preoperative diagnostics and care, postoperative care and patient follow-up also witnessed many improvements. Also, due to the retrospective nature of this study, the length of follow-up for each procedure group varied. Although the current findings are encouraging, the shorter follow-up period after the ASO procedure decreases the quality of comparison with the longer follow-up of Mustard and Senning patients. These factors, along with the centralization of surgical care to Helsinki since 1997 must be taken into account when comparing ASO to the Mustard and Senning procedures in this retrospective study [9] .
CONCLUSIONS
In conclusion, late survival after ASO is excellent. The risk of early heart failure and sudden death during the first 2 decades after the ASO is diminished compared with the Mustard and Senning procedures. Surgical techniques for the translocation of the coronary arteries developed, and early mortality after ASO decreased, further improving the excellent late outcomes for patients undergoing ASO in more recent eras. Also, perioperative treatment and intensive care has improved during recent eras, significantly attributing to the superior late survival of patients after the ASO procedure. However, an extended follow-up is required to assess the possibility of late sequelae beyond 20 and even 30 years after the ASO procedure, especially the effect of any residual lesions.
